中国现代医学杂志2018，Vol.28Issue(16)：113-116,4.DOI:10.3969/j.issn.1005-8982.2018.16.023
MELD、MESO、iMELD对失代偿期肝硬化患者短期预后的评估价值
Value of MELD, MESO and iMELD in evaluation of short-term prognosis of patients with decompensated liver cirrhosis
韩怡 1胡乃中2
作者信息
- 1. 安徽医科大学阜阳医院 消化内科,安徽 阜阳 236000
- 2. 安徽医科大学第一附属医院,安徽 合肥 230022
- 折叠
摘要
Abstract
ObjectiveTo evaluate the clinical value of model for end-stage liver disease (MELD), MELD to serum sodium ratio (MESO) and integrated MELD (iMELD) in prediction of short-term prognosis of patients with decompensated liver cirrhosis.Methods MELD, MESO and iMELD scores were assessed in 112 patients with decompensated liver cirrhosis. The accuracy of the three scoring systems in predicting survival was analyzed and compared using the area under the receiver operating characteristic (ROC) curve (AUC).Results There were significant differences in MELD, MESO and iMELD scores between the death group and the survival group after follow-up for 3 and 6 m. The AUC value of iMELD score was higher than those of MESO and MELD scores, the AUC value of MESO score was higher than that of MELD score after follow-up for 3 and 6 m (P < 0.05). Conclusions MELD, MESO and iMELD scores can accurately predict the short-term prognosis in patients with decompensated liver cirrhosis, while iMELD score is superior to the MESO score, and MESO score is superior to the MELD score.关键词
MELD/MESO/iMELD/肝硬化/预后Key words
model for end-stage liver disease/MELD to serum sodium ratio/iMELD/liver cirrhosis/prognosis分类
医药卫生引用本文复制引用
韩怡,胡乃中..MELD、MESO、iMELD对失代偿期肝硬化患者短期预后的评估价值[J].中国现代医学杂志,2018,28(16):113-116,4.
